What Happened?
Seattle, WA-based Alpine Immune Sciences Appointed Christina Yi as Chief Technology Officer
About the Company
Alpine Immune Sciences is a clinical stage biopharmaceutical company dedicated to discovering and developing innovative, protein-based immunotherapies targeting the immune synapse to treat autoimmune and inflammatory diseases. We have two products in the clinic for inflammatory diseases, collaborations with world-class partners, and a robust development pipeline. Traded on NASDAQ under ticker ALPN.
About the Person
Christina Yi is Chief Technology Officer at Alpine Immune Sciences. Previously, Christina held various senior IT leadership roles in the industry.
Info Source
News
Short Profile